BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference

BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference

WALTHAM, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc.
(Nasdaq:BGMD), a commercial stage company that is focused on the development
and delivery of diagnostic solutions to aid in the clinical management of
heart failure and related disorders, announced today that Dr. Paul Sohmer, BG
Medicine's President and CEO, will be presenting at the Baird 2013 Health Care
Conference on September 10, 2013, at The New York Palace, beginning at 2:20 PM
Eastern Time (ET).

Audio and slides of BG Medicine's presentation will be webcast at:
http://wsw.com/webcast/baird35/BGMD. The webcast will be archived for 30 days
following the live presentation on BG Medicine's Investor Relations website at
ir.BG-medicine.com.

About BG Medicine

BG Medicine, Inc. (Nasdaq:BGMD) is a commercial stage company that is focused
on the development and delivery of diagnostic solutions to aid in the clinical
management of heart failure and related disorders. For additional information
about BG Medicine, heart failure and galectin-3 testing, please visit
www.BG-medicine.com and www.galectin-3.com. The BG Medicine Inc. logo is
available for download here

CONTACT: Chuck Abdalian
         EVP & Chief Financial Officer
         (781) 434-0210

BG Medicine Inc. logo
 
Press spacebar to pause and continue. Press esc to stop.